RABOME

Regenerative Arthritis & Bone Medicine, Inc.

Home
About RABOME
Technology
News And Events
Contact Us

News And Events

UC Davis licenses novel compound to Rabome Inc.
02/2017
UC Davis licenses novel compound that helps stem cells regenerate bone to treat bone diseases
CIRM funded Treatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells
08/2013 to now
Treatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells
UC DAVIS Health Release
02/08/2012
UC DAVIS Investigators Develop Method of Directing Stem Cells to Increase Bone Formation and Bone Strength
Fighting Aging
02/2012
Directing Stem Cells to Enhance Bone Strength
Nature Review
02/2012
Bone: Homing MSCs to the surface of bones
NIH Research Highlight
02/2012
New Method to Build Bone

Copyright ©2013 RABOME. All rights reserved.